| Bioactivity | Formononetin-d3-1 is the deuterium-labeled Formononetin (HY-N0183)[1]. | ||||||||||||
| Invitro | 氢、碳和其他元素的稳定重同位素已被纳入药物分子中，主要作为药物开发过程中定量的示踪剂。氘化引起了人们的关注，因为它可能影响药物的药代动力学和代谢谱[1]。 | ||||||||||||
| Name | Formononetin-d3-1 | ||||||||||||
| Formula | C16H9D3O4 | ||||||||||||
| Molar Mass | 271.28 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. |